Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress

Document Details

Document Type
Pub Defense Publication
Publication Date
May 01, 2020
Source ID
10.1016/j.celrep.2020.107669

Entities

People

  • Alexandra Corella
  • Arja Kaipainen
  • Bruce Montgomery
  • Colin C Pritchard
  • Colm Morrissey
  • Eva Corey
  • Gail Petuna Risbridger
  • Gavin Ha
  • Ilsa M. Coleman
  • Jared Lucas
  • John T Isaacs
  • Lisa Ang
  • Michael D. Nyquist
  • Navonil De Sarkar
  • Payel Chatterjee
  • Peter S Nelson
  • Roman Gulati

Organizations

  • Congressionally Directed Medical Research Programs
  • Foundation for the National Institutes of Health